Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies
Immune checkpoint inhibitors (ICIs) targeting PD-1 and CTLA-4 have achieved groundbreaking clinical success in multiple cancers; however, a large proportion of patients experience primary or acquired resistance. This review synthesizes the complex mech…